(1 - 14 von 14
)
newsbreak.com
www.newsbreak.com
UPDATE: Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm. By Ben Adams,
sortiert nach Relevanz / Datum